Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gonzalez

Showing results (621-630 of 653) with videos related to

Pageof 66
Sort By:
Gastroenterology|November 2, 2010
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis CKathleen B Schwarz, Regino P Gonzalez-Peralta, Karen F Murray, et al.
Pediatric Transplantation|July 23, 2019
A learning health network for pediatric liver transplantation: Inaugural meeting report from the Starzl Network for Excellence in Pediatric TransplantationJames E Squires, Beth Logan, Angela Lorts, et al.
The Journal of Clinical Investigation|June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosisCyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
Hepatology Communications|November 10, 2018
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4Daniel H Leung, Stefan Wirth, Betty B Yao, et al.
Viruses|January 22, 2022
The Molecular Characterization of Hepatitis A Virus Strains Circulating during Hepatitis A Outbreaks in São Paulo, Brazil, from September 2017 to May 2019Samira Chuffi, Michele S Gomes-Gouvêa, Luciana V B Casadio, et al.
Pediatric Transplantation|October 22, 2022
Feasibility of using a patient-reported outcome measure into clinical practice following pediatric liver transplantation: The Starzl Network experienceVicky Lee Ng, Claire Dunphy, Eyal Shemesh, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine-TemporinGabriel Antunes Santoro, Natalia Caroline Souza Costa, Sarah Tolentino Rocha Brandão, et al.
Hepatology Communications|February 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling studyRegino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 9, 2021
A Learning Health System for Pediatric Liver Transplant: The Starzl Network for Excellence in Pediatric TransplantationEmily R Perito, James E Squires, David Bray, et al.
Pageof 66

Showing results (621-630 of 653) with videos related to

Sort By:
Pageof 66
Gastroenterology|November 2, 2010
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis CKathleen B Schwarz, Regino P Gonzalez-Peralta, Karen F Murray, et al.
Pediatric Transplantation|July 23, 2019
A learning health network for pediatric liver transplantation: Inaugural meeting report from the Starzl Network for Excellence in Pediatric TransplantationJames E Squires, Beth Logan, Angela Lorts, et al.
The Journal of Clinical Investigation|June 20, 2017
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosisCyrielle Caussy, Meera Soni, Jeffrey Cui, et al.
Hepatology Communications|November 10, 2018
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4Daniel H Leung, Stefan Wirth, Betty B Yao, et al.
Viruses|January 22, 2022
The Molecular Characterization of Hepatitis A Virus Strains Circulating during Hepatitis A Outbreaks in São Paulo, Brazil, from September 2017 to May 2019Samira Chuffi, Michele S Gomes-Gouvêa, Luciana V B Casadio, et al.
Pediatric Transplantation|October 22, 2022
Feasibility of using a patient-reported outcome measure into clinical practice following pediatric liver transplantation: The Starzl Network experienceVicky Lee Ng, Claire Dunphy, Eyal Shemesh, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine-TemporinGabriel Antunes Santoro, Natalia Caroline Souza Costa, Sarah Tolentino Rocha Brandão, et al.
Hepatology Communications|February 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling studyRegino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, et al.
Hepatology (Baltimore, Md.)|August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11Karen F Murray, William F Balistreri, Sanjay Bansal, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 9, 2021
A Learning Health System for Pediatric Liver Transplant: The Starzl Network for Excellence in Pediatric TransplantationEmily R Perito, James E Squires, David Bray, et al.
Pageof 66